We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
+16.63%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$30.8B
AUM Growth
+$5.31B
Cap. Flow
+$1.39B
Cap. Flow %
4.5%
Top 10 Hldgs %
6.07%
Holding
3,708
New
800
Increased
1,115
Reduced
1,029
Closed
741

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$187M
2
WMT icon
Walmart Inc
WMT
+$173M
3
DG icon
Dollar General
DG
+$171M
4
BMY icon
Bristol-Myers Squibb
BMY
+$164M
5
AMZN icon
Amazon
AMZN
+$162M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.5%
2 Technology 14.07%
3 Healthcare 12.37%
4 Industrials 9.06%
5 Financials 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LPCN icon
2951
Lipocine
LPCN
$17M
$34K ﹤0.01%
+860
New +$26.4K
ENT
2952
DELISTED
Global Eagle Entertainment Inc.
ENT
$33K ﹤0.01%
+1,875
New +$107K
VATE icon
2953
INNOVATE Corp
VATE
$102M
$30K ﹤0.01%
+1,217
New +$37.9K
TRIB
2954
Trinity Biotech
TRIB
$8.4M
$29K ﹤0.01%
68
-60
-47% -$24.7K
LGCY
2955
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$28K ﹤0.01%
56,760
-60,646
-52% -$81.8K
OBE
2956
Obsidian Energy
OBE
$769M
$26K ﹤0.01%
13,630
-892
-6% -$2.37K
MNKD icon
2957
MannKind Corp
MNKD
$1.31B
$24K ﹤0.01%
+11,991
New +$19K
VBIV
2958
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$19K ﹤0.01%
336
-1,329
-80% -$71.9K
TLGT
2959
DELISTED
Teligent, Inc
TLGT
$19K ﹤0.01%
+1,609
New +$24.3K
UQM
2960
DELISTED
UQM Technologies, Inc.
UQM
$19K ﹤0.01%
+11,741
New +$17.8K
IMUX icon
2961
Immunic
IMUX
$225M
$18K ﹤0.01%
231
-291
-56% -$25.6K
APVO icon
2962
Aptevo Therapeutics
APVO
$4.34M
0
GPUS
2963
Hyperscale Data Inc
GPUS
0
PRSO icon
2964
Peraso
PRSO
$10.1M
$3K ﹤0.01%
22
BLIN icon
2965
Bridgeline Digital
BLIN
$12.1M
$2K ﹤0.01%
266
-66
-20% -$796
A icon
2966
CALL
Agilent Technologies
A
$43.3B
-5,000
Closed -$337K
A icon
2967
PUT
Agilent Technologies
A
$43.3B
-3,200
Closed -$216K
AAL icon
2968
American Airlines Group
AAL
$9.02B
-37,599
Closed -$1.26M
AAP icon
2969
Advance Auto Parts
AAP
$2.63B
-934,980
Closed -$151M
AAPL icon
2970
Apple
AAPL
$4.53T
-609,556
Closed -$25.9M
ABCB icon
2971
Ameris Bancorp
ABCB
$5.77B
-21,952
Closed -$695K
ACA icon
2972
Arcosa
ACA
$7.13B
-11,949
Closed -$331K
ACN icon
2973
Accenture
ACN
$114B
-206,605
Closed -$32.5M
ADC icon
2974
Agree Realty
ADC
$9.28B
-85,060
Closed -$5.03M
ADTN icon
2975
Adtran
ADTN
$628M
-97,667
Closed -$1.05M

Similar funds

John Overdeck's Q1 2019 Portfolio in Review

As of Q1 2019, John Overdeck held 3,708 positions worth $30.8B, up 21% from $25.5B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

John Overdeck deployed $1.39B of net new capital in Q1 2019, opening 800 new positions and adding to 1,115 existing holdings. Its largest new stake was Dollar General: 1,470,962 shares worth $175M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Netflix, an estimated $243M trimmed.

  • John Overdeck's largest Q1 2019 buy was Dollar General: 1,470,962 shares worth $175M.
  • John Overdeck added most to AbbVie in Q1 2019, an estimated $187M increase.
  • John Overdeck's biggest Q1 2019 reduction was Netflix, cutting an estimated $243M.
  • John Overdeck fully exited Boeing in Q1 2019, selling an estimated $202M.
  • John Overdeck's ten largest holdings make up 6.1% of its $30.8B portfolio in Q1 2019.
  • John Overdeck opened 800 new positions and closed 741 in Q1 2019.
  • John Overdeck's portfolio value rose 21% quarter-over-quarter to $30.8B.

Based on Two Sigma Investments's 13F filing for Q1 2019, filed 15 May 2019.